[Form 4] BIO-TECHNE Corp Insider Trading Activity
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Bio‑Techne (TECH) reported an insider equity event by its President, Protein Sciences. On 11/03/2025, 9,911 shares were acquired at $0 upon settlement of restricted stock units, followed by the disposition of 4,520 shares at $62.57, typically associated with tax withholding. After these transactions, the officer directly owned 20,503 common shares.
The filing also lists outstanding equity awards, including stock options with expirations through 2035 and various time- and performance-based RSUs, indicating future vesting schedules tied to service and performance conditions.
Positive
- None.
Negative
- None.
Insider Trade Summary
9,911 shares exercised/converted
Mixed
14 txns
Insider
Geist William
Role
PRESIDENT, PROTEIN SCIENCES
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 9,911 | $0.00 | -- |
| Exercise | Common Stock | 9,911 | $0.00 | -- |
| Tax Withholding | Common Stock | 4,520 | $62.57 | $283K |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Performance Restricted Stock Units | -- | -- | -- |
| holding | Performance Stock Options (Right to Buy) | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Performance Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
| holding | Performance Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Stock Options (Right to Buy) | -- | -- | -- |
Holdings After Transaction:
Restricted Stock Units — 0 shares (Direct);
Common Stock — 25,023 shares (Direct);
Stock Options (Right to Buy) — 15,912 shares (Direct);
Performance Restricted Stock Units — 9,074 shares (Direct);
Performance Stock Options (Right to Buy) — 24,424 shares (Direct)
Footnotes (1)
- Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock. Options to purchase 3,980 shares vest on each of 2/1/2023 and 2/1/2025, and options to purchase 3,976 shares vest on each of 2/1/2024 and 2/1/2026. Options to purchase 7,400 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026. Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). Options to purchase 7,515 shares vest on each of 8/15/2024, 8/15/2025, 8/15/2027, and 7,514 shares vest on 8/15/2026. 9,911 restricted stock units vest on 11/1/2025. Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). 2,623 restricted stock units vest on each of 8/15/2026 and 8/15/2027. Options to purchase 5,301 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028. Vests in full or in part on 8/15/2028 if certain performance goals are achieved (or such later date as performance is certified by the Administrator). 3,226 restricted stock units vest on each of 8/15/2026, 8/15/2027 and 8/15/2028. Options to purchase 8,253 shares vest on each of 8/15/2026 and 8/15/2027, and options to purchase 8,252 shares vest on 8/15/2028.
